Jinyu Bio-Technology Co (600201.SS) Stock Price

Jinyu Bio-Technology Co Price

SSE·CLOSED
13.09
​
Market closed

Over the last 19 years Jinyu Bio-Technology Co grew revenue by 4.9% annually, reaching 1.40 B CNY. Earnings per share have grown at 5.1% per year over the last 19 years. For Jinyu Bio-Technology Co, the net margin of 7.2% is down versus 21.5% a few years ago. At today's price the dividend yield works out to roughly 0.23%. The payout ratio is around 32% of earnings. The dividend has grown at 8.6% per year over the past 19 years. The consensus 12-month price target for Jinyu Bio-Technology Co is 10.20 CNY, about 22.1% below where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.

Jinyu Bio-Technology Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jinyu Bio-Technology Co business model & stock analysis

Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas.

Frequently asked questions about Jinyu Bio-Technology Co

Analysts currently set an average price target of 13.15 CNY for the Jinyu Bio-Technology Co stock (median: 10.20 CNY), implying +0.3 % versus the latest price. The consensus is based on 6 analyst ratings.

6 analysts currently rate the Jinyu Bio-Technology Co stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Jinyu Bio-Technology Co to generate revenue of 1.63 B CNY and earnings per share of 0.20 CNY.

Converted at the current exchange rate, the Jinyu Bio-Technology Co share trades at 1.75 EUR (13.09 CNY).

The Jinyu Bio-Technology Co share (600201.SS) is listed on 1 stock exchanges, including: Shanghai (600201.SS).

The expected revenue of Jinyu Bio-Technology Co is 1.63 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Jinyu Bio-Technology Co is 217.97 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Jinyu Bio-Technology Co is currently 64.57. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Jinyu Bio-Technology Co stock.

The price-to-sales ratio (P/S) of Jinyu Bio-Technology Co is currently 8.62. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Jinyu Bio-Technology Co stock.

The Eulerpool Quality Score for Jinyu Bio-Technology Co is 3/10.

The ISIN of Jinyu Bio-Technology Co is CNE000000Y37. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Jinyu Bio-Technology Co is 600201.SS. The ticker symbol is used to trade Jinyu Bio-Technology Co shares on the stock exchange.

Fair ValueTerminal
13.74 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
863,049.26 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website jinyu.com.cn
Country
Currency
CNY
Initial public offering
Jan 15, 1999
ISIN
CNE000000Y37
Cusip
Y4085H105
Market capitalization
14.27 B CNYLarge Cap
52-Week Range
PEG
6.86
P/E ratio
P/Ee 2026
65.45
P/Ee 2027
54.54
P/Ee 2028
37.40
P/Se
8.62
EV/EBIT
119.14
P/B Ratio
2.66
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.86 %
Dividend
Dividend yield
0.23 %
Est. Dividend Yield
0.28 %
Payout Ratio
32.22 %
Dividend growth Ø5Y
-19.58 %
Dividend payments per year
1
Dividend paid since
14 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 27, 2026, 1:38 PM

Jinyu Bio-Technology Co Peer Group

Jinyu Bio-Technology Co Ticker

SHH · 600201.SS

Jinyu Bio-Technology Co FIGI

600201:CH · BBG000BPJYQ8600201:CG · BBG000BPJZK1600201:C1 · BBG00709HJ59